Andy Pasternak

CIK 1792746 · EVP, Chief Strategy Officer · last filed 2025-06-12

Andy Pasternak is an EVP, Chief Strategy Officer who has filed 23 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for CNTX, was dated Jun 12, 2025. Across all open-market trades the lifetime net is −$13.9M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

23

Lifetime Open-Market Net

-$13.92M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CNTX Director $1.39 $0 2 2025-06-12
Horizon Therapeutics Public Ltd Co (HZNP) Delisted EVP, Chief Strategy Officer 0 $116.30 $0 -$13.92M 21 2023-10-06

Recent Filings

23 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-06-12 CNTX Grant (A) $0 EDGAR
2025-01-14 CNTX Grant (A) $0 EDGAR
2023-10-06 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Disp (D) −56,338 -$6.56M EDGAR
2023-01-18 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Sell (S) −27,129 -$3.07M EDGAR
2023-01-06 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Grant (A) $0 EDGAR
2023-01-04 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Mixed +49,420 -$4.47M EDGAR
2022-12-29 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Grant (A) $0 EDGAR
2022-12-14 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Mixed −6,918 -$2.71M EDGAR
2022-11-02 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Mixed +6,918 -$347.7K EDGAR
2022-07-29 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Sell (S) −4,850 -$400.5K EDGAR
Showing 110 of 23
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.